APA (7th ed.) Citation

A, B., HD, T., EL, S., A, C., M, D. B., S, B., . . . K, E. (2021). Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA dermatology, 157(9), 1047. https://doi.org/10.1001/jamadermatol.2021.3023

Chicago Style (17th ed.) Citation

A, Blauvelt, et al. "Efficacy and Safety of Upadacitinib Vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial." JAMA Dermatology 157, no. 9 (2021): 1047. https://doi.org/10.1001/jamadermatol.2021.3023.

MLA (9th ed.) Citation

A, Blauvelt, et al. "Efficacy and Safety of Upadacitinib Vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial." JAMA Dermatology, vol. 157, no. 9, 2021, p. 1047, https://doi.org/10.1001/jamadermatol.2021.3023.